A Novel Prodrug Strategy Based on Reversibly Degradable Guanidine Imides for High Oral Bioavailability and Prolonged Pharmacokinetics of Broad-Spectrum Anti-influenza Agents

Affiliations

Yujeong Jung: Department of Chemistry, College of Natural Sciences, Seoul National University, Seoul, Republic of Korea
Soo Bin Ahn: Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
Taeyang An: Department of Chemistry and Biochemistry, University of California, La Jolla, California, United States
Hyeon-Min Cha: Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
Minjae Kim: Department of Chemistry, College of Natural Sciences, Seoul National University, Seoul, Republic of Korea
Hyunjin Cheon: Department of Chemistry, College of Natural Sciences, Seoul National University, Seoul, Republic of Korea
Yejin Jang: Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
Haemi Lee: Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
Byungil Kim: Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
Meehyein Kim: Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
Yan Lee: Department of Chemistry, College of Natural Sciences, Seoul National University, Seoul, Republic of Korea

Abstract

No abstracts available.